In Korea, stem cell treatments are classified as drugs, and they have to go through rigorous clinical trials to prove their safety and efficacy before being approved.
국내에서는 줄기세포 치료제가 약품으로 분류돼 엄격한 임상시험을 거쳐 안전성과 약효를 입증해야 허가를 받을 수 있다.